L’avis intitulé « Vaccin antigrippal INFLUVAC : transition du vaccin antigrippal INFLUVAC, de sa forme quadrivalente à une forme trivalente, dans la stratégie de vaccination contre la grippe saisonnière », ci-joint, est adopté.
Voir aussi
Recommandation vaccinale
20/12/2024
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
KwnVdhjzYcTrK0jH
